These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33626889)

  • 1. Remote Hemodynamic-Guided Therapy of Patients With Recurrent Heart Failure Following Cardiac Resynchronization Therapy.
    Varma N; Bourge RC; Stevenson LW; Costanzo MR; Shavelle D; Adamson PB; Ginn G; Henderson J; Abraham WT;
    J Am Heart Assoc; 2021 Feb; 10(5):e017619. PubMed ID: 33626889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower Rates of Heart Failure and All-Cause Hospitalizations During Pulmonary Artery Pressure-Guided Therapy for Ambulatory Heart Failure: One-Year Outcomes From the CardioMEMS Post-Approval Study.
    Shavelle DM; Desai AS; Abraham WT; Bourge RC; Raval N; Rathman LD; Heywood JT; Jermyn RA; Pelzel J; Jonsson OT; Costanzo MR; Henderson JD; Brett ME; Adamson PB; Stevenson LW;
    Circ Heart Fail; 2020 Aug; 13(8):e006863. PubMed ID: 32757642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions Linked to Decreased Heart Failure Hospitalizations During Ambulatory Pulmonary Artery Pressure Monitoring.
    Costanzo MR; Stevenson LW; Adamson PB; Desai AS; Heywood JT; Bourge RC; Bauman J; Abraham WT
    JACC Heart Fail; 2016 May; 4(5):333-44. PubMed ID: 26874388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remote Hemodynamic Monitoring Equally Reduces Heart Failure Hospitalizations in Women and Men in Clinical Practice: A Sex-Specific Analysis of the CardioMEMS Post-Approval Study.
    DeFilippis EM; Henderson J; Axsom KM; Costanzo MR; Adamson PB; Miller AB; Brett ME; Givertz MM
    Circ Heart Fail; 2021 Jun; 14(6):e007892. PubMed ID: 34129363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary Artery Pressure-Guided Heart Failure Management Reduces 30-Day Readmissions.
    Adamson PB; Abraham WT; Stevenson LW; Desai AS; Lindenfeld J; Bourge RC; Bauman J
    Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27220593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Practice-Based Management of Pulmonary Artery Pressures in 2000 Patients Implanted With the CardioMEMS Sensor.
    Heywood JT; Jermyn R; Shavelle D; Abraham WT; Bhimaraj A; Bhatt K; Sheikh F; Eichorn E; Lamba S; Bharmi R; Agarwal R; Kumar C; Stevenson LW
    Circulation; 2017 Apr; 135(16):1509-1517. PubMed ID: 28219895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary Artery Pressure-Guided Management of Patients With Heart Failure and Reduced Ejection Fraction.
    Givertz MM; Stevenson LW; Costanzo MR; Bourge RC; Bauman JG; Ginn G; Abraham WT;
    J Am Coll Cardiol; 2017 Oct; 70(15):1875-1886. PubMed ID: 28982501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wireless pulmonary artery pressure monitoring guides management to reduce decompensation in heart failure with preserved ejection fraction.
    Adamson PB; Abraham WT; Bourge RC; Costanzo MR; Hasan A; Yadav C; Henderson J; Cowart P; Stevenson LW
    Circ Heart Fail; 2014 Nov; 7(6):935-44. PubMed ID: 25286913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and feasibility of pulmonary artery pressure-guided heart failure therapy: rationale and design of the prospective CardioMEMS Monitoring Study for Heart Failure (MEMS-HF).
    Angermann CE; Assmus B; Anker SD; Brachmann J; Ertl G; Köhler F; Rosenkranz S; Tschöpe C; Adamson PB; Böhm M
    Clin Res Cardiol; 2018 Nov; 107(11):991-1002. PubMed ID: 29777373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
    Linde C; Gold MR; Abraham WT; St John Sutton M; Ghio S; Cerkvenik J; Daubert C;
    Eur Heart J; 2013 Sep; 34(33):2592-9. PubMed ID: 23641006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary artery sensor system pressure monitoring to improve heart failure outcomes (PASSPORT-HF): rationale and design of the PASSPORT-HF multicenter randomized clinical trial.
    Störk S; Bernhardt A; Böhm M; Brachmann J; Dagres N; Frantz S; Hindricks G; Köhler F; Zeymer U; Rosenkranz S; Angermann C; Aßmus B
    Clin Res Cardiol; 2022 Nov; 111(11):1245-1255. PubMed ID: 35246723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of remote haemodynamic monitoring by an implantable pulmonary artery pressure monitoring sensor (CardioMEMS-HF system) in chronic heart failure in the Netherlands.
    Mokri H; Clephas PRD; de Boer RA; van Baal P; Brugts JJ; Rutten-van Mölken MPMH
    Eur J Heart Fail; 2024 May; 26(5):1189-1198. PubMed ID: 38560762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of cardiac resynchronization therapy on hospitalizations in the Resynchronization-Defibrillation for Ambulatory Heart Failure trial.
    Gillis AM; Kerr CR; Philippon F; Newton G; Talajic M; Froeschl M; Froeschl S; Swiggum E; Yetisir E; Wells GA; Tang AS
    Circulation; 2014 May; 129(20):2021-30. PubMed ID: 24610807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Outcomes With Cardiac Resynchronization Therapy in Patients With Mild Heart Failure With Moderate Renal Dysfunction.
    Daimee UA; Moss AJ; Biton Y; Solomon SD; Klein HU; McNitt S; Polonsky B; Zareba W; Goldenberg I; Kutyifa V
    Circ Heart Fail; 2015 Jul; 8(4):725-32. PubMed ID: 26038537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac resynchronization therapy in patients with heart failure and a QRS complex <120 milliseconds: the Evaluation of Resynchronization Therapy for Heart Failure (LESSER-EARTH) trial.
    Thibault B; Harel F; Ducharme A; White M; Ellenbogen KA; Frasure-Smith N; Roy D; Philippon F; Dorian P; Talajic M; Dubuc M; Guerra PG; Macle L; Rivard L; Andrade J; Khairy P;
    Circulation; 2013 Feb; 127(8):873-81. PubMed ID: 23388213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Extrapolation of Clinical Benefits Among Patients With Mild Heart Failure Receiving Cardiac Resynchronization Therapy: Analysis of the 5-Year Follow-Up From the REVERSE Study.
    Gold MR; Padhiar A; Mealing S; Sidhu MK; Tsintzos SI; Abraham WT
    JACC Heart Fail; 2015 Sep; 3(9):691-700. PubMed ID: 26277764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Empagliflozin Effects on Pulmonary Artery Pressure in Patients With Heart Failure: Results From the EMBRACE-HF Trial.
    Nassif ME; Qintar M; Windsor SL; Jermyn R; Shavelle DM; Tang F; Lamba S; Bhatt K; Brush J; Civitello A; Gordon R; Jonsson O; Lampert B; Pelzel J; Kosiborod MN
    Circulation; 2021 Apr; 143(17):1673-1686. PubMed ID: 33550815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic-guided heart-failure management using a wireless implantable sensor: Infrastructure, methods, and results in a community heart failure disease-management program.
    Jermyn R; Alam A; Kvasic J; Saeed O; Jorde U
    Clin Cardiol; 2017 Mar; 40(3):170-176. PubMed ID: 27878990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inverse Relationship of Blood Pressure to Long-Term Outcomes and Benefit of Cardiac Resynchronization Therapy in Patients With Mild Heart Failure: A Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy Long-Term Follow-Up Substudy.
    Biton Y; Moss AJ; Kutyifa V; Mathias A; Sherazi S; Zareba W; McNitt S; Polonsky B; Barsheshet A; Brown MW; Goldenberg I
    Circ Heart Fail; 2015 Sep; 8(5):921-6. PubMed ID: 26179186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Ambulatory Hemodynamic Monitoring of Heart Failure With Clinical Outcomes in a Concurrent Matched Cohort Analysis.
    Abraham J; Bharmi R; Jonsson O; Oliveira GH; Artis A; Valika A; Capodilupo R; Adamson PB; Roberts G; Dalal N; Desai AS; Benza RL
    JAMA Cardiol; 2019 Jun; 4(6):556-563. PubMed ID: 31090869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.